Saturday, August 06, 2011
A weekly topotecan and biweekly bevacizumab combination demonstrates acceptable toxicity and encouraging efficacy in patients with platinum-resistant
Note: pay particular attention to the side effects/adverse events
RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: Is the evidence sufficient to change practice?
Conclusion: A survey of gynaecologists revealed that few currently appear to adhere to the College Statement regarding prophylactic oophorectomy at the time of hysterectomy for benign disease. High quality evidence regarding either harm or benefit following retention of ovaries after menopause is lacking. Nevertheless, dialogue between clinicians and patients on this topic is important.
Cancers | Free Full-Text | Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines (including ovarian cancer)
Download PDF Full-Text [270 KB, uploaded 5 August 2011 17:58 CET]
Advocates Partnership Program Opportunities | Genetic Alliance - deadline to apply Aug 26th - Montreal conference
Advocates Partnership Program
at the International Congress of Human Genetics
October 11-15, 2011 ● Montreal, Canada
Deadline to Apply: August 26, 2011
conference notice: Welcome to the 12th International Congress of Human Genetics annual meeting (Montreal)
On behalf of The American Society of Human Genetics (ASHG) and the International Federation of Human Genetics Societies (IFHGS), it gives us great pleasure to invite human geneticists from all around the world to attend and participate in the 12th International Congress of Human Genetics (ICHG) and the 61st ASHG Annual Meeting. The Congress will be held at the Le Palais des Congrès (Convention Center) in Montreal (Quebec), Canada from Tuesday, October 11th through Saturday, October 15th 2011, coinciding with the ASHG meeting.
The ICHG is the foremost meeting of the world human genetics community and is held every five years. The first Congress was held in 1956 in Copenhagen and subsequent venues have included Berlin, Washington, DC, Rio de Janeiro, Vienna and most recently Brisbane. The anticipated attendance is 7,000 delegates from over 60 countries around the world.
Membership in the American Society of Professionals in Patient Safety is open to professionals whose primary responsibility is patient safety, as well as to individuals across other healthcare disciplines, medical students, providers, risk managment and quality leaders, patient safety advocates and all those committed to safe patient care. Individual membership is the newest addition to NPSF’s portfolio, which includes continuing education credits through the Professional Learning Series, the NPSF Annual Patient Safety Congress, and other high-value programs. S